Apr 09, 2024
Penumbra, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024
Feb 01, 2024
Penumbra, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 22, 2024
Feb 10, 2021
Penumbra, Inc. to Present at Citi's 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference
Feb 02, 2021
Penumbra, Inc. Schedules Fourth Quarter and Full Year 2020 Earnings Release and Conference Call for February 23, 2021
Jan 19, 2021
Genesis Medtech Collaborates with Penumbra to Expand Neurovascular Market in China
Dec 08, 2020
Penumbra Responds to False Allegations from Short Sellers Seeking to Manipulate Company Stock and Remove Life-saving Medical Devices from the Market
Dec 04, 2020
Penumbra, Inc. to Participate in CEO Discussion with Bank of America
Nov 10, 2020
Penumbra Announces Partnership with RapidAI to Enable Faster Clinical Decision-Making for Pulmonary Embolism
Nov 06, 2020
Penumbra, Inc. to Present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum
Aug 03, 2020
Penumbra, Inc. Reports Second Quarter 2020 Financial Results
Jul 20, 2020
Penumbra, Inc. Schedules Second Quarter 2020 Earnings Release and Conference Call for August 3, 2020
May 27, 2020
Penumbra, Inc. Announces Pricing of Offering of Common Stock
May 27, 2020
Penumbra, Inc. Announces Launch of Offering of $100,000,000 of Shares of its Common Stock
May 12, 2020
Penumbra Announces Management Transition
Apr 23, 2020
Penumbra, Inc. Schedules First Quarter 2020 Earnings Release and Conference Call for May 7, 2020
Apr 06, 2020
Penumbra Provides Update on COVID-19 Response and Impact
Nov 25, 2019
Maggie Yuen Appointed Chief Financial Officer Of Penumbra
Nov 19, 2019
Penumbra, Inc. Announces Investor Day 2019
Nov 07, 2019
Penumbra, Inc. Reports Third Quarter 2019 Financial Results
Oct 17, 2019
Penumbra, Inc. Schedules Third Quarter 2019 Earnings Release and Conference Call for November 7, 2019